Skip to main content

Clinical trial CARRISMM

Evaluation of the impact of the update multiple myeloma criteria on the natural history of smoldering myeloma in order to establish new recommendations about follow-up and prognostic evaluation of smoldering myeloma

Cancers
Organ Myeloma
Trial status Trial closed for recruitment
Investigator
Trial type
Interventional without experimental drug
Academic trial Oui
Sponsor IFM
BECT Identifier B4032020000006
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT04144387
Inclusion criteria Smoldering myeloma defined by IMWG 2014 criteriaDiagnosed less than 1 year before the inclusion
Last update